Attogene Corporation
Austin, TX
- UEI
- M5VSPH6FK6D6
- CAGE
- 5K6J2
- Primary NAICS
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- Other NAICS codes in SAM.gov
- SAM.gov registration date
- Physical address
- 3913 Todd Ln #310, Austin, TX 78744, USA
- Website
- attogene.com
- Founded
- 2012
- Employees
- 1-10
- Estimated annual revenue
- $0-$1M
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Biotechnology
- SIC code
- 87 Engineering & Management Services
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Contract awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Microcystin congeners LR & RR | Office of Acquisitions and Grants (USGS) | $50,753 |
Grant awards
Latest 5 listed here. See the rest on GovTribe.
Similar vendors
About the company
Attogene Corporation is a biotechnology company based in Austin, Texas, registered in SAM.gov since 2010 and classified as a self-certified small disadvantaged business, for-profit organization, and manufacturer of goods. The company specializes in developing innovative diagnostic and detection technologies, with a focus on creating rapid, portable, and sensitive testing solutions for various environmental and biomedical applications. As a small business, Attogene Corp has successfully secured multiple federal grant awards from key scientific research agencies, demonstrating its capacity to develop cutting-edge technological solutions addressing critical public health and environmental challenges.
The company has been awarded several significant federal grants from agencies like the National Institute of Environmental Health Sciences (NIEHS) and the National Institute of General Medical Sciences (NIGMS), focusing on developing advanced detection and screening technologies. These grants include a $257,312 project to create a novel electrochemical biosensor for detecting organophosphate and carbamate pesticides, a $229,975 grant to develop a rapid lateral flow assay for detecting ribonucleases in RNA-based therapeutic manufacturing, and another grant to create a screening test for dihydroanatoxin-A, a toxin derived from cyanobacteria. Each project shares a common theme of developing portable, cost-effective, and rapid testing methodologies that can be used in field settings, laboratories, and manufacturing environments. The grants primarily support Phase I research and development efforts, with completion dates ranging from August 2024 to June 2026, indicating Attogene Corporation's ongoing commitment to innovative scientific research and technological solution development.
Quick answers
Is Attogene Corporation registered in SAM.gov?
Yes. Attogene Corporation's SAM.gov registration is active through June 8, 2027.
What is Attogene Corporation's CAGE code?
Attogene Corporation's CAGE code is 5K6J2, and its Unique Entity ID (UEI) is M5VSPH6FK6D6.
What is Attogene Corporation's most recent federal award?
Attogene Corporation's most recent federal grant award is Development of a novel electrochemical pesticide sensor (R43ES038029), from National Institute of Environmental Health Sciences (NIH), on August 26, 2025.
On GovTribe
See Attogene Corporation's full federal record
- Federal contract awards
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors